AcuCort is in an expansion phase, with growth driven through partnerships with companies responsible for marketing and sales in their respective markets. Frisk will take overall responsibility for further developing these collaborations, with a focus on expanding market presence, driving sales growth, and building long-term value.

Frisk brings extensive experience in sales, marketing, and business development within the pharmaceutical industry. He has previously held senior commercial roles at Unimedic Pharma, Sanofi, and Grünenthal Sweden, where he was responsible for sales and marketing in the Nordic market. Through these roles, he has built up substantial experience in developing markets, establishing partnerships, and driving commercial growth.

“Carl Frisk has solid experience from the pharmaceutical industry, an extensive network, and deep knowledge of AcuCort. He will play an important role in further developing our partnerships and creating the conditions for increased sales in our markets,” says AcuCort CEO Jonas Jönmark.

“AcuCort has an attractive product and a clear international strategy. I see great opportunities to work together with our partners to further develop the company’s commercial presence and contribute to increased sales in our markets,” says Frisk.